KATHERINE TACKETT: Open Payments
NPI 1821682741 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,150 in 83 payments from 22 companies in 2025. Trend: 2023 $16 · 2024 $1,478 · 2025 $2,150
Food & beverage: $2,026Education: $124
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $519 |
| GENZYME CORPORATION | 15 | $379 |
| Amgen Inc. | 12 | $283 |
| GlaxoSmithKline, LLC. | 13 | $164 |
| Novartis Pharmaceuticals Corporation | 8 | $138 |
| SANOFI-AVENTIS U.S. LLC | 1 | $90 |
| Grifols USA, LLC | 4 | $83 |
| ABBVIE INC. | 4 | $78 |
| Blueprint Medicines Corporation | 2 | $66 |
| CSL Behring | 3 | $49 |
Products named: DUPIXENT, TEZSPIRE, AIRSUPRA, TRELEGY ELLIPTA, AYVAKIT, Rhapsido, Xembify, RINVOQ.
Industry payments across OH — which companies pay providers there.
